Main Menu
MSAA
  • Toll-Free Helpline Call Us Toll Free (800) 532-7667 Search
  • Get MS Updates
  • Información en Español
  • Donate
  • Skip main navigation
MSAA logo
  • MS Information
    • MS Overview & Glossary
    • Newly Diagnosed
    • Symptoms
    • Treatments
    • COVID-19 and MS
    • Prescription Assistance Programs
    • Clinical Trials Search
    • Publications
    • Latest News from MSAA
    • MSi Videos
    • Podcasts from MSAA
    • Toll-free Helpline & Chat
    • Información en Español
    • MS FAQs
  • How MSAA Can Help
    • Toll-free Helpline & Chat
    • Publications
    • MSi Videos
    • Cooling Products
    • Equipment Products
    • MRI Access Program
    • Educational Programs
    • Shared-Management Tools
    • Overall Wellness
    • Online Aquatic Center
    • FAQs
  • Living with MS
    • My MSAA Community
    • MS Conversations Blog
    • My MS Journey
    • My MS Manager™ Mobile App
    • MS Relapse Resource Center
    • My Health Insurance Guide
    • My MS Resource Locator
    • Overall Wellness
    • Online Aquatic Center
    • Educational Programs
  • Donate
    • Make A Donation
    • Honor and Memorial Donations
    • Become a Monthly Improver
    • Planned Giving
    • Other Ways to Give
      • Donor-Advised Funds
      • Vehicle Donation
      • Matching Gifts
      • Shop & Support MSAA
    • Donation FAQs
  • Get Involved
    • Special Events
    • Art Showcase
    • Do-It-Yourself Fundraiser
    • Partnerships
    • Volunteer With MSAA
    • FAQ
  • Calendar
  • About MSAA
    • Mission and Overview
    • MSAA’s 50th Anniversary
    • MS Awareness Month
    • MSAA Achievements
    • Contact Us
    • Board of Directors
    • Healthcare Advisory Council
    • African American Advisory Board
    • Hispanic/Latinx Advisory Board
    • MSAA Strategic Plan
    • Navigating MS
    • MS Coalition
    • Annual Report
    • Financial Information
  • Search

Type of MS treating: Secondary-progressive MS (active)

Briumvi™

Read News Article

Zeposia®

Read News Article

Vumerity®

Read News Article

Tysabri®

Read News Article

Tecfidera®

Read News Article

Rebif®

Read News Article

Ponvory®

Read News Article

Plegridy®

Read News Article

Ocrevus®

Read News Article

Novantrone®

Read News Article

Posts navigation

1 2 Next
Latest News
Latest News Photo

What’s New in MS Research – March 2023

Read More


The Multiple Sclerosis Association of America (MSAA) Focuses on MS at All Stages of Life During MS Awareness Month

Read More


What’s New in MS Research – January 2023

Read More


FDA Approves Briumvi™ for the Treatment of Relapsing Forms of MS

Read More


What’s New in MS Research – November 2022

Read More


In Remembrance: Jack Burks, MD

Read More


What’s New in MS Research – September 2022

Read More


View All News

My MSAA Community

Latest MSi Videos Latest MSi Videos
Family Planning and Multiple Sclerosis
Family Planning and Living with MS
Intimacy with MS: Understanding Affectionate, Romantic, & Self Love
La toma compartida de decisiones y la adherencia al tratamiento en EM

MSAA on Instagram

msassociation

msassociation

msassociation


View


Mar 31


Open


The latest edition of “What’s New in MS Research” features a wide variety of topics and recent research findings.

To read this new edition, please visit the link in our bio.

.

[ID: Text - "What's New in MS Research." Underneath the text are illustrations of a microscope and a beaker.]
#msawareness #msresearch

The latest edition of “What’s New in MS Research” features a wide variety of topics and recent research findings.

To read this new edition, please visit the link in our bio.

.

[ID: Text – "What's New in MS Research." Underneath the text are illustrations of a microscope and a beaker.]
#msawareness #msresearch …



Follow MSAA on Instagram


    • MSAA logo
    • (800) 532-7667
    • msaa@mymsaa.org
    • MSAA is a 501(C)(3) nonprofit registered in the US under EIN: 22-1912812.Copyright ©2023 Multiple Sclerosis Association of America.Reproduction of material from any mymsaa.org pages without written permission is strictly prohibited.
    • GET EMAIL UPDATES
    • Privacy Policy and Terms of Use
    • Donor Privacy Policy
    • Financial Information
    • Información en Español
    • Contact Us
    • HONCODE
    • Guidestar Logo
    • America's Charities
    • Facebook
    • Twitter
    • Instagram
    • Tik Tok
    • Pinterest
    • YouTube
    • LinkedIn
    • ESSENTIAL
    • Accessibility Statement

Last modified:

×